TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Ame Bioscience AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
516
|
1,905
|
2,453 |
Financial expenses |
2
|
9
|
4 |
Earnings before taxes |
97
|
391
|
587 |
Total assets |
471
|
770
|
1,954 |
Current assets |
471
|
769
|
1,953 |
Current liabilities |
110
|
104
|
1,573 |
Equity capital |
361
|
666
|
381 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) | 1 | 1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
76.6%
|
86.5%
|
19.5% |
Turnover per employee | 516 | 2,453 | |
Profit as a percentage of turnover |
18.8%
|
20.5%
|
23.9% |
Return on assets (ROA) |
21.0%
|
51.9%
|
30.2% |
Current ratio |
428.2%
|
739.4%
|
124.2% |
Return on equity (ROE) |
26.9%
|
58.7%
|
154.1% |
Change turnover |
-1,268
|
-420
|
2,294 |
Change turnover % |
-71%
|
-18%
|
1439% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.